Display options
Cite
Arnold KM, Flynn NJ, Sims-Mourtada J. Activation of Inflammatory Responses Correlate With Hedgehog Activation and Precede Expansion of Cancer Stem-Like Cells in an Animal Model of Residual Triple Negative Breast Cancer after Neoadjuvant Chemotherapy. Cancer Stud Mol Med. 2015;2(2):80-86doi: 10.17140/CSMMOJ-2-112.
Arnold, K. M., Flynn, N. J., & Sims-Mourtada, J. (2015). Activation of Inflammatory Responses Correlate With Hedgehog Activation and Precede Expansion of Cancer Stem-Like Cells in an Animal Model of Residual Triple Negative Breast Cancer after Neoadjuvant Chemotherapy. Cancer studies and molecular medicine : open journal, 2(2), 80-86. https://doi.org/10.17140/CSMMOJ-2-112
Arnold, Kimberly M, et al. "Activation of Inflammatory Responses Correlate With Hedgehog Activation and Precede Expansion of Cancer Stem-Like Cells in an Animal Model of Residual Triple Negative Breast Cancer after Neoadjuvant Chemotherapy." Cancer studies and molecular medicine : open journal vol. 2,2 (2015): 80-86. doi: https://doi.org/10.17140/CSMMOJ-2-112
Arnold KM, Flynn NJ, Sims-Mourtada J. Activation of Inflammatory Responses Correlate With Hedgehog Activation and Precede Expansion of Cancer Stem-Like Cells in an Animal Model of Residual Triple Negative Breast Cancer after Neoadjuvant Chemotherapy. Cancer Stud Mol Med. 2015;2(2):80-86. doi: 10.17140/CSMMOJ-2-112. Epub 2015 Dec 07. PMID: 28203638; PMCID: PMC5305183.
Copy Download .nbib Format: NLM
Share it on

Cancer Stud Mol Med. 2015;2(2):80-86. doi: 10.17140/CSMMOJ-2-112. Epub 2015 Dec 07.

Activation of Inflammatory Responses Correlate With Hedgehog Activation and Precede Expansion of Cancer Stem-Like Cells in an Animal Model of Residual Triple Negative Breast Cancer after Neoadjuvant Chemotherapy.

Cancer studies and molecular medicine : open journal

Kimberly M Arnold, Nicole J Flynn, Jennifer Sims-Mourtada

Affiliations

  1. Center for Translational Cancer Research, Helen F. Graham Cancer Center, Christiana Care Health Services, Inc., Newark, DE, USA; Department of Medical Laboratory Sciences, University of Delaware, Newark, DE, USA.
  2. Center for Translational Cancer Research, Helen F. Graham Cancer Center, Christiana Care Health Services, Inc., Newark, DE, USA; Department of Biological Sciences, University of Delaware, Newark, DE, USA.
  3. Center for Translational Cancer Research, Helen F. Graham Cancer Center, Christiana Care Health Services, Inc., Newark, DE, USA; Department of Medical Laboratory Sciences, University of Delaware, Newark, DE, USA; Department of Biological Sciences, University of Delaware, Newark, DE, USA.

PMID: 28203638 PMCID: PMC5305183 DOI: 10.17140/CSMMOJ-2-112

Abstract

Triple Negative Breast Cancer (TNBC) is characterized as a lack of expression of the hormonal receptors, estrogen and progesterone, and Human epidermal growth factor receptor 2 (HER2) and as such is unresponsive to current targeted therapy. Resistance of breast cancers to treatment is thought to be due to a sub-population of tumor cells called Breast Cancer Stem Cells (BCSCs) and contributes to poor prognosis and increased risk of recurrence. Previously, we have shown that hedgehog activation is induced by chemotherapy and promotes expansion of a stem-like population in breast cancer cell lines. In addition, chemotherapy can induce an inflammatory response and inflammatory factors can lead to activation of Hedgehog (HH) at sites of tissue injury. Therefore, we wanted to investigate how chemotherapy altered hedgehog signaling and correlated with the release of inflammatory cytokines in a mouse model of breast cancer. Patient derived triple negative breast tumor bearing mice were treated with weekly doses of docetaxel. Following treatment, tumor volume decreased reaching a nadir around 15 days after the start of treatment and increased back to pre-treatment size 35-39 days post treatment. Immunohistochemical staining of mice tumors revealed that Sonic hedgehog and nuclear Gli-1 expression transiently increased following docetaxel treatment, reached peak expression at day 8, and subsequently decreased to almost pre-treatment levels following regrowth of the tumor. Similarly, Interleukin 6 (IL-6) and Interleukin 8 (IL-8) expression transiently increased, peaked around day 8, and decreased upon tumor regrowth, however, remained above pre-treatment levels. Expression of the stem cell marker ALDH1A3 proceeded activation of hedgehog signaling and expression of inflammatory cytokines, increasing around day 15 post treatment and continued to be elevated during tumor regrowth. Thus, chemotherapy treatment resulted in activation of the hedgehog pathway and release of inflammatory cytokines leading to long-term expansion of ALDH1A3 positive stem cells, which can contribute to the regrowth of the tumor and promote resistance to treatment.

Keywords: Hedgehog signaling; Inflammatory cytokines; Neoadjuvant therapy; Triple negative breast cancer

Conflict of interest statement

CONFLICTS OF INTEREST The authors report no conflict with this work.

References

  1. Cancer Res. 2006 Jun 15;66(12 ):6063-71 - PubMed
  2. Biomed Res Int. 2014;2014:525680 - PubMed
  3. Nat Med. 2014 Oct;20(10):1182-6 - PubMed
  4. Stem Cells. 2012 May;30(5):833-44 - PubMed
  5. Int J Legal Med. 1996;108(5):231-6 - PubMed
  6. Genes Dev. 2001 Dec 1;15(23):3059-87 - PubMed
  7. Clin Cancer Res. 2011 Oct 1;17(19):6125-9 - PubMed
  8. J Clin Oncol. 2008 Mar 10;26(8):1275-81 - PubMed
  9. FASEB J. 2007 May;21(7):1358-66 - PubMed
  10. J Clin Invest. 2010 Feb;120(2):485-97 - PubMed
  11. Breast Cancer Res. 2014 May 27;16(3):R52 - PubMed
  12. Oncologist. 2011;16 Suppl 1:1-11 - PubMed
  13. Cancer Growth Metastasis. 2015 Jan 29;8:1-13 - PubMed
  14. Clin Cancer Res. 2013 May 15;19(10):2723-33 - PubMed
  15. Cancer Cell. 2007 Mar;11(3):259-73 - PubMed
  16. Cell Stem Cell. 2011 May 6;8(5):552-65 - PubMed
  17. Mol Oncol. 2015 Jan;9(1):17-31 - PubMed
  18. Physiol Rev. 2003 Jul;83(3):835-70 - PubMed
  19. Mol Carcinog. 2015 Nov;54(11):1480-93 - PubMed
  20. Diabetes. 2013 Jan;62(1):124-36 - PubMed
  21. Stem Cells. 2011 Jan;29(1):32-45 - PubMed
  22. Wound Repair Regen. 2008 Nov-Dec;16(6):768-73 - PubMed
  23. Exp Mol Pathol. 2012 Oct;93(2):227-36 - PubMed

Publication Types

Grant support